Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Belite Bio, Inc. Sponsored ADR (BLTE) had Return on Equity of -24.79% for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
-- |
|
$-36.14M |
|
-- |
|
-- |
|
$40.00M |
|
$-40.00M |
|
$3.86M |
|
$-36.14M |
|
$-36.14M |
|
$-36.14M |
|
$-36.14M |
|
$-36.14M |
|
$-36.14M |
|
$-40.00M |
|
$-39.55M |
|
30.54M |
|
30.54M |
|
$-1.18 |
|
$-1.18 |
|
Balance Sheet Financials | |
$147.07M |
|
$0.44M |
|
$5.06M |
|
$152.13M |
|
$6.05M |
|
-- |
|
$0.26M |
|
$6.31M |
|
$145.82M |
|
$145.79M |
|
$145.82M |
|
31.83M |
|
Cash Flow Statement Financials | |
$-29.23M |
|
$-110.57M |
|
$83.59M |
|
$88.16M |
|
$31.68M |
|
$-56.48M |
|
$8.99M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
24.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Return on Equity |
-24.79% |
-24.79% |
|
-23.76% |
|
-24.79% |
|
$4.58 |
|
$-0.96 |
|
$-0.96 |